Original Research

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Wu B, Lu S, Zhang L, Zhuo RX, Xu HB, Huang SW

International Journal of Nanomedicine 2017, 12:1853-1862

Published Date: 8 March 2017